Epigenetic markers-based breast cancer early detection method development

T.G. Goncharova1, D.R. Kaidarova1, N.A. Omarbayeva1, A.B. Askandirova1,2, M.G. Orazgaliyeva1, D.G. Adilbay1, D. Cheishvili3,4, F. Vaisheva3, M. Szyf3,4

1. Kazakh Institute of Oncology and Radiology, Almaty, the Republic of Kazakhstan;
2. City Polyclinic of WWII Veterans, Almaty, the Republic of Kazakhstan;
3. McGill University, Montreal, Quebec, Canada;
4. HKG Epitherapeutics, Hong Kong

DOI: 10.52532/2663-4864-2020-4-58-29-35

УДК: 616-006.-07.-003.215:618.19+577.218

Год: 2020 выпуск: 58 номер: 4 страницы: 29-35

Скачать PDF: 2012.2-3.24-25_10.pdf

Ключевые слова: breast cancer (BC), epigenetics, DNA methylation, peripheral blood mononuclear cells (PBMC), early detection, biomarker.

Ссылка: T.G. Goncharova, D.R. Kaidarova, N.A. Omarbayeva, A.B. Askandirova, M.G. Orazgaliyeva, D.G. Adilbay, D. Cheishvili, F. Vaisheva, M. Szyf. Epigenetic markers-based breast cancer early detection method development. Oncology and Radiology of Kazakhstan, 2020, 58 (4), 29-35.

Ошибка: Контактная форма не найдена.